Two Faces of the Same Coin: A Case Report of Antiphospholipid Syndrome Nephropathy
  • Sofia Homem de Melo Marques
    Department of Nephrology, Centro Hospitalar São João, Porto
  • Hugo André Nascimiento Ferreira
    Department of Nephrology, Centro Hospitalar São João, Porto
  • Ana Teresa Pires de Morais Nunes
    Department of Nephrology, Centro Hospitalar São João, Porto
  • Roberto Nicolau Pestana Silva
    Department of Anatomic Pathology, Centro Hospitalar São João, Porto
  • Susana Maria Moreira Sampaio Norton
    Department of Nephrology, Centro Hospitalar São João, Porto

Keywords

Antiphospholipid syndrome, Antiphospholipid syndrome nephropathy, kidney biopsy, thrombotic microangiopathy

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease which can be primary or secondary to other autoimmune conditions and is defined by the occurrence of arterial or venous thrombosis, or pregnancy morbidity associated with persistently positive antiphospholipid antibodies (aPLA). The kidney may be affected by thrombosis at any level of its vasculature. When small vessels are involved, this results in thrombotic microangiopathy (TMA), which can manifest as either acute vaso-occlusive or chronic vascular lesions in glomeruli, arterioles and interlobular arteries. We report the case of 26-year-old man, with a previous medical history suggestive of APS, who was found to have a small elevation in serum creatinine. A kidney biopsy was performed and revealed features of chronic TMA. Anticoagulation was begun and kidney function remained stable. However, one year later, upon suspension of anticoagulation, the patient developed acute kidney injury and a second kidney biopsy showed acute TMA. This case describes different manifestations of antiphospholipid syndrome nephropathy (APSN) and highlights the importance of anticoagulation for thrombosis prevention.

VIEW THE ENTIRE ARTICLE

References

  • Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306.
  • Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2015;74:1011–1018.
  • Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012;157:47–58.
  • Views: 3747
    HTML downloads: 278
    PDF downloads: 456
    Figure 2 downloads: 0
    Letter of submission downloads: 0
    Copyright downloads: 0
    Figure 1 downloads: 0


    Published: 2017-04-27
    Issue: Vol. 4 No. 3 (view)


    How to cite:
    1.
    Marques SH de M, Nascimiento Ferreira HA, Pires de Morais Nunes AT, Pestana Silva RN, Moreira Sampaio Norton SM. Two Faces of the Same Coin: A Case Report of Antiphospholipid Syndrome Nephropathy. EJCRIM 2017;4 doi:10.12890/2017_000542.

    Similar Articles

    You may also start an advanced similarity search for this article.